7-117611735-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000492.4(CFTR):c.3294G>C(p.Trp1098Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W1098?) has been classified as Pathogenic.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.3294G>C | p.Trp1098Cys | missense_variant | 20/27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFTR | ENST00000003084.11 | c.3294G>C | p.Trp1098Cys | missense_variant | 20/27 | 1 | NM_000492.4 | ENSP00000003084.6 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 251088Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135690
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461466Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727026
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:3Other:1
Pathogenic, reviewed by expert panel | research | CFTR2 | Aug 31, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 26, 2024 | Variant summary: CFTR c.3294G>C (p.Trp1098Cys) results in a non-conservative amino acid change located in the ABC transporter type 1, transmembrane domain (IPR011527) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251088 control chromosomes. This variant has also been reported without the specification of the nucleotide level designation and a non-informative genotype (second allele not specified) in individuals with Cystic Fibrosis, and CBAVD (example, Perez_2007, Chavez-Saldana_2010, Saldana-Alvarez_2012). Additionally two different variants, namely, c.3294G>T (p.Trp1098Cys), and c.3292T>C (p.Trp1098Arg) have been classified internally classified on the pathogenic spectrum. Sick kids and the CFTR-France databases have reports of presumably the same patient, namely a newborn presenting with pulmonary symptoms, positive IRT, mildly elevated sweat chloride levels and p.F508del in trans. An additional study lists its presence (without nucleotide level specification) in cis with the 5T allele in an individual with CBAVD reportedly homozygous for the 5T allele (Danziger_2004). At least one publication reports experimental evidence evaluating an impact on protein function in-vitro (Han_2018). The most pronounced variant effect results in approximately 3.4% of normal residual CFTR function. The following publications have been ascertained in the context of this evaluation (PMID: 14998948, 10798368, 16963320, 21416780, 30046002, 32596391, 22103471). ClinVar contains an entry for this variant (Variation ID: 53709). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 30, 2023 | This variant disrupts the p.Trp1098 amino acid residue in CFTR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7537150, 8662892). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CFTR protein function. ClinVar contains an entry for this variant (Variation ID: 53709). This missense change has been observed in individual(s) with cystic fibrosis (PMID: 10798368, 14998948, 16963320, 21416780, 30046002, 32227567). This variant is present in population databases (rs397508533, gnomAD 0.006%). This sequence change replaces tryptophan, which is neutral and slightly polar, with cysteine, which is neutral and slightly polar, at codon 1098 of the CFTR protein (p.Trp1098Cys). - |
not provided, no classification provided | literature only | ClinVar Staff, National Center for Biotechnology Information (NCBI) | - | - - |
Cystic fibrosis;C5924204:CFTR-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | CFTR-France | Sep 08, 2020 | the variant causes a phenotype but regarding our data, we can't formally attribute it to CF, CFTR-RD or both - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at